⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27559866 | 0.79 | ALDH1A1 (0.42) | — | |
| SCHEMBL175574 | 0.77 | TSHR (0.39) | — | |
| SCHEMBL252883 | 0.77 | TSHR (0.39) | — | |
| SCHEMBL8291484 | 0.74 | — | — | |
| SCHEMBL4105322 | 0.74 | — | — | |
| SCHEMBL1839325 | 0.74 | — | — | |
| SCHEMBL5138203 | 0.74 | — | — | |
| SCHEMBL2744516 | 0.74 | — | — | |
| SCHEMBL16130339 | 0.72 | — | — | |
| SCHEMBL103350 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108713025-A | Slave single carrier for treating the heart patient's condition and other pathology expresses the composition and method of multiple biological activities polypeptide | 英特拉克森公司 | 2018-10-26 | — | — | CN | claimed |
| EP-3387010-A1 | COMPOSITIONS AND METHODS FOR EXPRESSION OF MULTIPLE BIOLOGICALLY ACTIVE POLYPEPTIDES FROM A SINGLE VECTOR FOR TREATMENT OF CARDIAC CONDITIONS AND OTHER PATHOLOGIES | Intrexon Corporation (US) | 2018-10-17 | — | — | EP | claimed |
| US-20170224687-A1 | COMPOUNDS FOR MODULATING TRPV3 FUNCTION | HYDRA BIOSCIENCES INC (US) | 2017-08-10 | — | — | US | claimed |
| WO-2017083750-A1 | COMPOSITIONS AND METHODS FOR EXPRESSION OF MULTIPLE BIOLOGICALLY ACTIVE POLYPEPTIDES FROM A SINGLE VECTOR FOR TREATMENT OF CARDIAC CONDITIONS AND OTHER PATHOLOGIES | INTREXON CORPORATION (US) | 2017-05-18 | — | — | WO | claimed |
| US-9486455-B2 | Compounds for modulating TRPV3 function | HYDRA BIOSCIENCES, INC. (US) | 2016-11-08 | — | — | US | claimed |
| US-20160113903-A1 | SirT INHIBITORS THAT BIND TO NAD | ELIXIR PHARMACEUTICALS, INC. (US) | 2016-04-28 | — | — | US | claimed |
| US-20150374719-A1 | METHODS FOR TREATING FUNGAL INFECTIONS | BRIGHAM YOUNG UNIVERSITY (US) | 2015-12-31 | — | — | US | claimed |
| US-20140163029-A1 | SirT INHIBITORS THAT BIND TO NAD | ELIXIR PHARMACEUTICALS, INC. (US) | 2014-06-12 | — | — | US | claimed |
| EP-2521548-A2 | QUINAZOLIN-4(3A)-ONE DERIVATIVES AND METHODS OF USE THEREOF | Proteologics, Ltd (IL) | 2012-11-14 | — | — | EP | claimed |
| EP-2421858-A1 | THIOXANTHENE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES | BKG Pharma ApS (DK) | 2012-02-29 | — | — | EP | claimed |
| WO-2004064745-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS, INC. (US) | 2004-08-05 | — | — | WO | claimed |
| EP-1373194-A1 | BENZAMIDE INHIBITORS OF FACTOR Xa | Millennium Pharmaceuticals, Inc. (US) | 2004-01-02 | — | — | EP | claimed |
| US-20030069250-A1 | Benzamide inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2003-04-10 | — | — | US | claimed |
| WO-2002079145-A1 | BENZAMIDE INHIBITORS OF FACTOR Xa | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-10-10 | — | — | WO | claimed |
| EP-0348261-B1 | Radiohalogenated compounds for site specific labeling | CYTOGEN CORP (US) | 1993-12-15 | — | — | EP | claimed |
| US-4966999-A | Radiohalogenated compounds for site specific labeling | CYTOGEN CORPORATION (US) | 1990-10-30 | — | — | US | claimed |
| EP-0348261-A1 | Radiohalogenated compounds for site specific labeling | CYTOGEN CORPORATION (US) | 1989-12-27 | — | — | EP | claimed |
| WO-1989011876-A1 | RADIOHALOGENATED COMPOUNDS FOR SITE SPECIFIC LABELING | CYTOGEN CORPORATION (US) | 1989-12-14 | — | — | WO | claimed |
| US-4464366-A | Cephem compounds having a terminal aminocarboxylic acid grouping and containing an azacyclyl(thio)ureido group | CIBA GEIGY CORPORATION (US) | 1984-08-07 | — | — | US | claimed |
| US-4337262-A | HYPOTENSIVE AGENT, ANTICOAGULANT, VASODILATION, ANTIULCER AGENT, BRONCHODILATOR AGENT, ANTIALLERGEN, AND CONTRACEPTIVE | BURROUGHS WELLCOME CO. (US) | 1982-06-29 | — | — | US | claimed |